Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function

Clinical Immunology

Volumn 91, Issue 3, 1999, Pages 243-253

  Rawlings, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cell antigen receptor (BCR); IP3; PLC ; XID; XLA

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE DIFFERENTIATION; CELL DEATH; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033013019     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4732     Document Type: Review

References (116)

1. Bruton O. C. Agammaglobulinemia. Pediatrics. 9:1952;722-727.
2. Bruton O., Apt L., Gitlin D., Janeway C. Absence of serum gamma globulins. Am. J. Dis. Child. 84:1952;632-636.
3. Conley M. E., Brown P., Pickard A. R., Buckley R. H., Miller D. S., Raskind W. H., Singer J. W., Fialkow P. J. Expression of the gene defect in X-linked agammaglobulinemia. N. Engl. J. Med. 315:1986;564-567.
4. Campana D., Farrant J., Inamdar N., Webster A. D. B., Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J. Immunol. 145:1990;1675-1680.
5. Pearl E. R., Vogler L. B., Okos A. J., Crist W. M., Lawton A. R. III, Cooper M. D. B lymphocyte precursors in human bone marrow: An analysis of normal individuals and patients with antibody-deficiency states. Immunol. 120:1978;1169-1175.
6. Wicker L. S., Scher I. X-linked immune deficiency (xid) of CBA/N mice. Curr. Top. Microbiol. Immunol. 124:1986;87-101.
7. Hitoshi Y., Sonoda E., Kikuchi Y., Yonehara S., Nakauchi H., Takatsu K. IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int. Immunol. 5:1993;1183-1190.
8. Go N. F., Castle B. E., Barret R., Kastelein R., Dang W., Mosmann T. R., Moore K. W., Howard M. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1990;1625-1631.
9. Santos-Argumedo L., Lund F. E., Heath A. W., Solvason N., Wu W. W., Grimaldi J. C., Parkhouse R. M. E., Howard M. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int. Immunol. 7:1995;163-170.
10. Miyake K., Yamashita Y., Hitoshi Y., Takatsu K., Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: Unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180:1994;1217-1224.
11. Hasbold J., Klaus G. G. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur. J. Immunol. 24:1994;152-157.
12. Rawlings D. J., Witte O. N. The Btk subfamily of cytoplasmic tyrosine kinases: Structure, regulation, and function. Semin. Immunol. 7:1995;237-246.
13. Tsukada S., Saffran D. C., Rawlings D. J., Parolini O., Allen R. C., Klisak I., Sparkes R. S., Kubagawa H., Mohandas T., Quan S., Belmont J. W., Cooper M. D., Conley M. E., Witte O. N. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 72:1993;279-290.
14. Vetrie D., Vorechovsky I., Sideras P., Holland J., Davies A., Flinter F., Hammarstrom L., Kinnon C., Levinsky R., Bobrow M., Smith C. I. E., Bentley D. R. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 361:1993;226-233.
15. Rawlings D. J., Saffran D. C., Tsukada S., Largaespada D. A., Grimaldi J. C., Cohen L., Mohr R. N., Bazan J. F., Howard M., Copeland N. G., Jenkins N. A., Witte O. N. Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 261:1993;358-361.
16. Thomas J. D., Sideras P., Smith C. I., Vorechovsky I., Chapman V., Paul W. E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 261:1993;355-358.
17. Rawlings D. J., Witte O. N. "Immunological Reviews" 1994;Munksgaard, Copenhagen. p. 105-119.
18. Sideras P., Smith C. I. E. Molecular and Cellular Aspects of X-linked agammaglobulinemia. Adv. Immunol. 59:1995;135-223.
19. Conley M. E., Cooper M. D. Genetic basis of abnormal B cell development. Curr. Opin. Immunol. 10:1998;399-406.
20. Smith C., Witte O. N. Ochs H. D., Smith C. I. E., Puck J. M. "Primary Immunodeficiency Diseases: A Molecular and Genetic Approach" 1999;263-284 Oxford Univ. Press, New York.
21. Cooley L. Drosophila ring canal growth requires Src and Tec kinases. Cell. 93:1998;913-915.
22. de Weers M., Verschuren M. C. M., Kraakman M. E. M., Mensink R. G. J., Schuurman R. K. B., van Dongen J. J. M., Hendriks R. W. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 23:1993;3109-3114.
23. Smith C. I. E., Baskin B., Humire-Greiff P., Zhou J.-n., Olsson P. G., Maniar H. S., Kjell n. P., Lambris J. D., Christensson B., Hammarström L., Bentley D., Vetrie D., Islam K. B., Vorechovsky I., Sideras P. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 152:1994;557-565.
24. Bolen J. B. Nonreceptor tyrosine protein kinases. Oncogene. 8:1993;2025-2031.
25. Pawson T. Protein modules and signalling networks. Nature. 373:1995;573-580.
26. Guinamard R., Fougereau M., Seckinger P. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand. J. Immunol. 45:1997;587-595.
27. Bunnell S. C., Henry P. A., Kolluri R., Kirchhausen T., Rickles R. J., Berg L. J. Identification of Itk/Tsk Src homology 3 domain ligands. J. Biol. Chem. 271:1996;25646-25656.
28. Baba Y., Nonoyama S., Matsushita M., Yamadori T., Hashimoto S., Imai K., Arai S., Kunikata T., Kurimoto M., Kurosaki T., Ochs H. D., Yata J., Kishimoto T., Tsukada S. Involvement of Wiskott-Aldrich Syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 93:1999;2003-2012.
29. Resh M. D. Myristylation and palmitylation of Src family members: The fats of the matter. Cell. 76:1994;411-413.
30. Cooper J. A., Howell B. The when and how of src regulation. Cell. 63:1993;1051-1054.
31. Vihinen M., Nilsson L., Smith C. I. E. Tec homology (TH) adjacent to the PH domain. FEBS Lett. 350:1994;263-265.
32. Gibson T. J., Hyvonen M., Musacchio A., Saraste M., Birney E. PH domain: The first anniversary. Trends Biochem. Sci. 19:1994;349-353.
33. Lemmon M. A., Ferguson K. M., Schlessinger J. PH domains: Diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell. 85:1996;621-624.
34. Hyvönen M., Saraste M. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: Molecular explanations for X-linked agammaglobulinaemia. EMBO J. 16:1997;3396-3404.
35. Tsukada S., Simon M., Witte O., Katz A. Binding of the βγ subunits of heterotrimeric G-proteins to the PH domain of Bruton's tyrosine kinase. Proc. Natl. Acad. Sci. USA. 91:1994;11256-11260.
36. Yang W., Desiderio S. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc. Natl. Acad. Sci. USA. 94:1997;604-609.
37. Novina C. D., Cheriyath V., Roy A. L. Regulation of TFII-I activity by phosphorylation. J. Biol. Chem. 273:1998;33443-33448.
38. Jiang Y., Ma W., Wan Y., Kozasa T., Hattori S., Huang X. Y. The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. Nature. 395:1998;808-813.
39. Cheng G., Ye Z.-S., Baltimore D. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. USA. 91:1994;8152-8155.
40. Andreotti A. H., Bunnell S. C., Feng S., Berg L. J., Schreiber S. L. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature. 385:1997;93-97.
41. Park H., Wahl M. I., Afar D. E., Turck C. W., Rawlings D. J., Tam C., Scharenberg A. M., Kinet J.-P., Witte O. N. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity. 4:1996;515-525.
42. Vihinen M., Brandau O., Branden L. J., Kwan S. P., Lappalainen I., Lester T., Noordzij J. G., Ochs H. D., Ollila J., Pienaar S. M., Riikonen P., Saha B. K., Smith C. I. E. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 26:1998;242-247.
43. Vihinen M., Cooper M. D., de Saint Basile G. v., Fischer A., Good R. A., Hendriks R. W., Kinnon C., Kwan S.-P., Litman G. W., Notarangelo L. D., Ochs H. D., Rosen F. S., Vetrie D., Webster A. D. B., Zegers B. J. M., Smith C. I. E. BTKbase: A database of XLA-causing mutations. Immunol. Today. 16:1995;460-465.
44. Futatani T., Miyawaki T., Tsukada S., Hashimoto S., Kunikata T., Arai S., Kurimoto M., Niida Y., Matsuoka H., Sakiyama Y., Iwata T., Tsuchiya S., Tatsuzawa O., Yoshizaki K., Kishimoto T. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood. 91:1998;595-602.
45. Salim K., Bottomley M. J., Querfurth E., Zvelebil M. J., Gout I., Scaife R., Margolis R. L., Gigg R., Smith C. I. E., Driscoll P. C., Waterfield M. D., Panayotou G. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. Oncogene. 15:1996;6241-6250.
46. Fukuda M., Kojima T., Kabayama H., Mikoshiba K. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J. Biol. Chem. 271:1996;30303-30306.
47. Wortis H. H., Burkly L., Hughes D., Roschelle S., Waneck G. Lack of mature B cells in nude mice with X-linked immune deficiency. J. Exp. Med. 155:1982;903-913.
48. Chung H. Y., Dong Z., Wortis H. H. B cell deficiency progresses with lineage maturation in nude X-linked immunodeficient mice. J. Immunol. 149:1992;3456-3462.
49. de Weers M., Brouns G. S., Hinshelwood S., Kinnon C., Schuurman R. K. B., Hendriks R. W., Borst J. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269:1994;23857-23860.
50. Kerner J. D., Appleby M. W., Mohr R. N., Chien S., Rawlings D. J., Maliszewski C. R., Witte O. N., Perlmutter R. M. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 3:1995;301-312.
51. Khan W. N., Alt F. W., Gerstein R. M., Malynn B. A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A. B., Herzenberg L. A., Rosen F. S., Sideras P. Defective B-cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299.
52. Hendriks R. W., de Bruijn M. F. T. R., Maas A., Dingjan G. M., Karis A., Grosveld F. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15:1996;4862-4872.
53. Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S., Tarakhovsky A. Immunodeficiency in protein kinase cbeta-deficient mice. Science. 273:1996;788-791.
54. Zhang R., Alt F. W., Davidson L., Orkin S. H., Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 374:1995;470-473.
55. Fruman D. A., Snapper S. B., Yballe C. M., Davidson L., Yu J. Y., Alt F. W., Cantley L. C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science. 283:1999;393-397.
56. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 283:1999;390-392.
57. Sato S., Katagiri T., Takaki S., Kikuchi Y., Hitoshi Y., Yonehara S., Tsukada S., Kitamura D., Watanabe T., Witte O., Takatsu K. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Btk and JAK2 kinases. J. Exp. Med. 180:1994;2101-2111.
58. Kikuchi Y., Yasue T., Miyake K., Kimoto M., Takatsu K. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor α chain: Synergistic effects with interleukin 5. Proc. Natl. Acad. Sci. USA. 92:1995;11814-11818.
59. Matsuda T., Takahashi-Tezuka M., Fukada T., Okuyama Y., Fujitani Y., Tsukada S., Mano H., Hirai H., Witte O. N., Hirano T. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood. 85:1995;627-633.
60. Kawakami Y., Yao L., Miura T., Tsukada S., Witte O. N., Kawakami T. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol. Cell. Biol. 14:1994;5108-5113.
61. Ma Y. C., Huang X. Y. Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase. Proc. Natl. Acad. Sci. USA. 95:1998;12197-12201.
62. Quek L. S., Bolen J., Watson S. P. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr. Biol. 8:1998;1137-1140.
63. Laffargue M., Ragab-Thomas J. M., Ragab A., Tuech J., Missy K., Monnereau L., Blank U., Plantavid M., Payrastre B., Raynal P., Chap H. Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets. FEBS Lett. 443:1999;66-70.
64. Rolink A., Melchers F. Molecular and cellular origins of B lymphocyte diversity. Cell. 66:1991;1081-1094.
65. Melchers F., Rolink A., Grawunder U., Winkler T. H., Karasuyama H., Ghia P., Andersson J. Positive and negative selection events during B lymphopoiesis. Curr. Opin. Immunol. 7:1995;214-227.
66. Saouaf S. J., Mahajan S., Rowley R. B., Kut S., Fargnoli J., Burkhardt A. L., Tsukada S., Witte O. N., Bolen J. B. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinase following B cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA. 91:1994;9524-9528.
67. Cambier J. C., Pleiman C. M., Clark M. R. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:1994;457-486.
68. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
69. DeFranco A. L. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:1997;296-308.
70. Kurosaki T. Molecular dissection of B cell antigen receptor signaling (review). Int. J. Mol. Med. 1:1998;515-527.
71. Rawlings D. J., Scharenberg A. M., Park H., Wahl M. I., Lin S., Kato R. M., Fluckiger A. C., Witte O. N., Kinet J. P. Activation of BTK by a phosphorylation mechanism initiated by Src family kinases. Science. 271:1996;822-825.
72. Afar D. E. H., Park H., Howell B. W., Rawlings D. J., Cooper J., Witte O. N. Regulation of Btk by Src family tyrosine kinases. Mol. Cell. Biol. 16:1996;3465-3471.
73. Wahl M. I., Fluckiger A.-C., Kato R. M., Park H., Witte O. N., Rawlings D. J. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc. Natl. Acad. Sci. USA. 94:1997;11526-11533.
74. Nisitani S., Kato R. M., Rawlings D. J., Witte O. N., Wahl M. I. In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 96:1999;2221-2226.
75. Rigley K. P., Harnett M. M., Phillips R. J., Klaus G. G. B. Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice. Eur. J. Immunol. 19:1989;2081-2086.
76. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
77. Fu C., Turck C. W., Kurosaki T., Chan A. C. BLNK: A central linker protein in B cell activation. Immunity. 9:1998;93-103.
78. Ishiai M., Kurosaki M., Pappu R., Okawa K., Ronko I., Fu C., Shibata M., Iwamatsu A., Chan A. C., Kurosaki T. BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity. 10:1999;117-125.
79. Scharenberg A. M., El-Hillal O., Fruman D. A., Beitz L. O., Li Z., Lin S., Gout I., Cantley L. C., Rawlings D. J., Kinet J. P. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals. EMBO J. 17:1998;1961-1972.
80. Fluckiger A. C., Li Z., Kato R. M., Wahl M. I., Ochs H. D., Longnecker R., Kinet J.-P., Witte O. N., Scharenberg A. M., Rawlings D. J. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J. 17:1998;1973-1985.
81. Liu K. Q., Bunnell S. C., Gurniak C. B., Berg L. J. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187:1998;1721-1727.
82. Takata M., Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma2. J. Exp. Med. 184:1996;31-40.
83. Hippen K. L., Buhl A. M., D'Ambrosio D., Nakamura K., Persin C., Cambier J. C. Fc gammaRIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+ mobilization is integrated by CD19 dephosphorylation. Immunity. 7:1997;49-58.
84. Putney J. W. Jr., Bird G. S. J. The signal for capacitative calcium entry. Cell. 75:1993;199-201.
85. Fanger C. M., Zweifach A., Dolmetsch R. E., Hoth M., Lewis R. S. Function follows form: The role of store-operated calcium channels in T-cell activation. Cell. Physiol. Biochem. 7:1997;203-218.
86. Parekh A. B., Fleig A., Penner R. The store-operated calcium current I(CRAC): Nonlinear activation by InsP3 and dissociation from calcium release. Cell. 89:1997;973-980.
87. Huang Y., Putney J. W. Jr. Relationship between intracellular calcium store depletion and calcium release-activated calcium current in a mast cell line (RBL-1). J. Biol. Chem. 273:1998;19554-19559.
88. Scharenberg A. M., Kinet J. P. PtdIns-3,4,5-P3: A regulatory nexus between tyrosine kinases and sustained calcium signals. Cell. 94:1998;5-8.
89. Muta T., Kurosaki T., Misulovin Z., Sanchez M., Nussenzweig M. C., Ravetch J. V. A 13-amino-acid motif in the cytoplasmic domain of FcgammaRIIB modulates B-cell receptor signalling. Nature. 368:1994;70-73.
90. Daeron M., Latour S., Malbec O., Espinosa E., Pina P., Pasmans S., Fridman W. H. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FccRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity. 3:1995;635-646.
91. Scharenberg A. M., Kinet J.-P. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell. 87:1996;961-964.
92. Bijsterbosch M. K., Klaus G. G. B. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Exp. Med. 162:1985;1825-1836.
93. Choquet D., Partisetti M., Amigorena S., Bonnerot C., Fridman W. H., Korn H. Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J. Cell Biol. 121:1993;355-363.
94. Diegel M. L., Rankin B. M., Bolen J. B., Dubois P. M., Kiener P. A. Cross-linking of Fc gamma receptor to surface immunoglobulin on B cells provides an inhibitory signal that closes the plasma membrane calcium channel. J. Biol. Chem. 269:1994;11409-11416.
95. Ono M., Okada H., Bolland S., Yanagi S., Kurosaki T., Ravetch J. B. Deletion of SHIP-1 reveals two distinct pathways for inhibitory signaling. Cell. 90:1997;293-301.
96. Bolland S., Pearse R. N., Kurosaki T., Ravetch J. V. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity. 8:1998;509-516.
97. Okada H., Bolland S., Hashimoto A., Kurosaki M., Kabuyama Y., Iino M., Ravetch J. V., Kurosaki T. Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response. J. Immunol. 161:1998;5129-5132.
98. Healy J. I., Dolmetsch R. E., Timmerman L. A., Cyster J. G., Thomas M. L., Crabtree G. R., Lewis R. S., Goodnow C. C. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:1997;419-428.
99. Benatar T., Carsetti R., Furlonger C., Kamalia N., Mak T., Paige C. J. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J. Exp. Med. 183:1996;329-334.
100. Ono M., Bolland S., Tempst P., Ravetch J. V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature. 383:1996;263-266.
101. O'Keefe T. L., Williams G. T., Davies S. L., Neuberger M. S. Hyperresponsive B cells in CD22-deficient mice. Science. 274:1996;798-801.
102. Goodnow C. C. Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA. 93:1996;2264-2271.
103. Dolmetsch R. E., Lewis R. S., Goodnow C. C., Healy J. I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 386:1997;855-858.
104. Bootman M. D., Berridge M. J. The elemental principles of calcium signaling. Cell. 83:1995;675-678.
105. Karasuyama H., Rolink A., Melchers F. Surrogate light chain in B cell development. Adv. Immunol. 63:1996;1-41.
106. Misener V., Downey G. P., Jongstra J. The immunoglobulin light chain related protein lambda 5 is expressed on the surface of mouse pre-B cell lines and can function as a signal transducing molecule. Int. Immunol. 3:1991;1129-1136.
107. Nomura J., Matsuo T., Kubota E., Kimoto M., Sakaguchi N. Signal transmission through the B cell-specific MB-1 molecule at the pre-B cell stage. Int. Immunol. 3:1991;117-126.
108. Nakamura T., Sekar M. C., Kubagawa H., Cooper M. D. Signal transduction in human B cells initiated via Ig beta ligation. Int. Immunol. 5:1993;1309-1315.
109. Nagata K., Nakamura T., Kitamura F., Kuramochi S., Taki S., Campbell K. S., Karasuyama H. The Ig alpha/Igbeta heterodimer on mu-negative proB cells is competent for transducing signals to induce early B cell differentiation. Immunity. 7:1997;559-570.
110. Neuberger M. S. Antigen receptor signaling gives lymphocytes a long life. Cell. 90:1997;971-973.
111. Klaus G. G., Johnson-Leger C., Elgueta-Karstegl C., Atkins C. A reevaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Eur. J. Immunol. 27:1997;2749-2756.
112. Oka Y., Rolink A. G., Andersson J., Kamanaka M., Uchida J., Yasui T., Kishimoto T., Kikutani H., Melchers F. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int. Immunol. 8:1996;1675-1685.
113. Khan W. N., Nilsson A., Mizoguchi E., Castigli E., Forsell J., Bhan A. K., Gesha R., Sideras P., Alt F. W. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int. Immunol. 9:1997;395-405.
114. Woodland R. T., Schmidt M. R., Korsmeyer S. J., Gravel K. A. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J. Immunol. 156:1996;2143-2154.
115. Solvason N., Wu W. W., Kabra N., Lund-Johansen F., Roncarolo M. G., Behrens T. W., Grillot D. A., Nunez G., Lees E., Howard M. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187:1998;1081-1091.
116. Anderson J. S., Teutsch M., Dong Z., Wortis H. H. An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;10966-10971.